|Basis of Allotment|
BROOKS LABORATORIES LIMITED
(Our Company was originally incorporated as Brooks Laboratories
Limited on January 23,2002 under the Companies Act, 1956 vide certification of
Incorporation bearing registration under 24910 issued by the Registar of the Companies,
Punjab, Himachal Pradesh and Chandigarh. There has no change in the name of the comapny
since incorporation. Our company has been allocated Corporate identification Number
U24232PB2002PLC024910 For details of change in our registered office, please refer to the
chapter titled "History and Certain Corporate Matters" on page 138 of the
Promoters of Our Company: Mr. Atul Ranchal and Mr. Rajesh Mahajan
BASIS OF ALLOTMENT
PUBLIC ISSUE OF 6,300,000 EQUITY SHARES OF FACE VALUE RS 10 EACH (THE "EQUITY SHARES") OF BROOKS LABORATORIES LIMITED ("OUR COMPANY" OR THE "ISSUER") FOR CASH AT A PRICE OF Rs 100 PER EQUITY SHARE (INCLUDING A SHARE PREMIUM OF Rs 90 PER EQUITY SHARE) AGGREGATING UP TO Rs 6300 LACS (THE "ISSUE"). THE ISSUE COMPRISES A NET ISSUE OF UPTO 6,300,000 EQUITY SHARES (THE "NET ISSUE"). THE ISSUE WILL CONSTITUTE 38.92 % OF THE FULLY DILUTED POST ISSUE PAID-UP CAPITAL OF OUR COMPANY.
THE FACE VALUE OF EACH EQUITY SHARE IS Rs 10 EACH. THE ISSUE PRICE IS 10
TIMES THE FACE VALUE
The Equity Shares of the Company are proposed to be listed on the Bombay Stock Exchange Limited ("BSE") and The National Stock Exchange of India Limited ("NSE") and the trading Is proposed to commence with effect from September 05,2011 #.
#Subject to receipt of listing and trading approval from the Stock Exchanges
The Issue is being made in terms of Rule 19(2)(b)(i) of the Securities Contracts Regulation Rules, 1957,as amended ("SCRR"), this is an issue of at least 25% of the post issue share capital of the Company. The Issue is being made through the book building process (the "Book Building Process") wherein not more than 50% of the Issue will be allocated to Qualified Institutional Buyers ("QlBs") on a proportionate basis, subject to valid bids being received at or above the Issue Price. Out of the portion available for allocation to the QIBs, 5% will be available for allocation to Mutual Funds only. Mutual Fund Bidders shall also be eligible for proportionate allocation under the balance available for the QIBs. Further, not less than 15% of the Issue shall be available for allocation on a proportionate basis to Non Institutional Bidders and not less than 35% of the Issue shall be available for allocation on a proportionate basis to Retail Individual Bidders, subject to valid bids being received at or above the Issue Price. All Bidders were allowed to participate in the Issue through the Application Supported by Blocked Amount ("ASBA") process by providing the details of their respective bank accounts in which the corresponding Bid amounts were blocked by Self Certified Syndicate Banks (the "SCSBs"). For details in this regard, specific attention is invited to Issue Procedure"
The Issue received 4,878 applications for 11,121,360 equity shares resulting in 1.7653 times subscription. The details of the applications received in the Issue from Retail Individual Investor and Non-Institutional Investors are as under: (Before technical rejections)
The under subscribed portion of 3,150,000 shares in QIB category has been spilled over to Retail and Nil category In the ratio of 70:30.
The Basis of Allocation was finalized in consultation with the Bombay Stock Exchange
Limited ("BSE") on August 26,2011 A. Allocation to Retail Individual
Investors (After Technical Rejections)
B. Allocation to Non Institutional Investors (After Technical Rejections)
The Basis of Allocation to the Non-Institutional Investors, who have bid at the Issue Price of Rs. 100 per Equity Share, was finalized in consultation with BSE. This category has been over subscribed to the extent of 1.5656 times. The total number of equity shares allotted in this category is 1,890,000 equity shares to 52 successful applicants. All the applicants in this category have been given firm allotment.
C. Allocation to Qualified Institutional Buyers (After Technical Rejections)
There were no applications received under this category, hence the under subscribed
portion of 31,50,000 shares in this category was spilled over to Retail and Nil category
in the ratio of 70:30.
The CAN-cum-Refund Orders and allotment advice and/ or notices have been dispatched to the address of the investors as registered with the depositories. Further, the instruction to the SCSBs for unblocking of funds has been sent on August 27,2011. In case the same is not received within ten days, investors may contact at the address given below. The Refund Orders have been over-printed with the Bank Account details as registered, if any, with the depositories. The shares allocated to successful applicants are being credited to their beneficiary accounts subject to validation of the account details with the depositories concerned.
INVESTORS PLEASE NOTE
These details of the allocation made would be hosted on the website of Registrars to the Offer, Link Intime India Private Limited at Website: www.linkintime.co.in
All future correspondence in this regard may kindly be addressed to the Registrars to the offer quoting full name of the First/ Sole applicant, Serial number of the bid-cum-application form, number of shares bid for, name of the Member of the Syndicate and Place where the bid was submitted and payment details at the address given below:
Link Intime India Private Limited
C-13, Pannalal Silk Mills Compound,
THE LEVEL OF SUBSCRIPTION SHOULD NOT BE TAKEN TO BE INDICATIVE OF EITHER THE MARKET PRICE OF THE EQUITY SHARE ON LISTING OR THE BUSINESS PROSPECTS OF BROOKS LABORATORIES LIMITED.
Note: All capitalized terms used and not defined herein shall have the respective meanings assigned to them in the prospectus dated August 22,2011 (the "Prospectus").